BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Operating Officer,
Andy Robbins, will present at the
Goldman Sachs 38th Annual Global Healthcare Conference. The
public is welcome to participate in the conference through a
webcast on the Array BioPharma website.
|
Event:
|
Goldman Sachs 38th
Annual Global Healthcare Conference
|
|
Presenter:
|
Andy Robbins, Chief
Operating Officer
|
|
Date:
|
Tuesday, June 13,
2017
|
|
Time:
|
10:00 a.m. Pacific
Time
|
|
Webcast:
|
https://cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Seven Array-owned or
partnered drugs are advancing in registration studies: binimetinib
(MEK162), encorafenib (LGX818), selumetinib (partnered with
AstraZeneca), danoprevir (partnered with Roche), larotrectinib
(partnered with Loxo Oncology), tucatinib (partnered with Cascadian
Therapeutics) and ipatasertib (partnered with Roche).
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300466999.html
SOURCE Array BioPharma Inc.